Radiant Innovation Inc. (TPEX:3373)
Taiwan · Delayed Price · Currency is TWD 18.80
-0.20 (-1.05%)
Oct 31, 2025, 1:30 PM CST
Radiant Innovation Market Cap
Radiant Innovation has a market cap or net worth of 895.23 million as of October 31, 2025. Its market cap has decreased by -10.28% in one year.
Market Cap
895.23M
Enterprise Value
773.67M
Revenue
418.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.80
Market Cap Chart
Since February 24, 2005, Radiant Innovation's market cap has increased from 300.96M to 895.23M, an increase of 197.46%. That is a compound annual growth rate of 5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 904.76M | -9.13% |
| Dec 31, 2024 | 995.67M | -13.53% |
| Dec 29, 2023 | 1.15B | -5.67% |
| Dec 30, 2022 | 1.22B | -24.40% |
| Dec 30, 2021 | 1.61B | -55.22% |
| Dec 31, 2020 | 3.61B | 400.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 181.96B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lotus Pharmaceutical | 75.87B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.13B |
| Polaris Group | 27.16B |
| Pegavision | 25.74B |